Indication: Used for adjuvant treatment of chronic hepatitis, persistent hepatitis, chronic cholangitis and cholecystitis, as well as chronic, superficial, atrophic gastritis and leukocytopenia caused by radiotherapy and chemotherapy.

Indication: Suitable for cholecystitis and cholangitis.

Indication: Suitable for cholecystitis and cholangitis.

Indication: This product can be used to treat the following infections caused by sensitive bacteria: respiratory tract infections (upper and lower respiratory tract infections), urinary tract infections (upper and lower urinary tract infections), peritoneal infections (upper and lower urinary tract infections), peritonitis, cholecystitis, cholangitis and other intracavitary infections, sepsis, meningitis, skin and soft tissue infections, bone and joint infections. Pelvic inflammatory disease, endometritis, gonorrhea and other genital and tract infections. Prevention of infection: used to prevent infections caused by intra-abdominal, gynecological, cardiovascular and orthopedic surgeries.

Indication: This product can be used to treat the following infections caused by sensitive bacteria: respiratory tract infections (upper and lower respiratory tract infections), urinary tract infections (upper and lower urinary tract infections), peritoneal infections (upper and lower urinary tract infections), peritonitis, cholecystitis, cholangitis and other intracavitary infections, sepsis, meningitis, skin and soft tissue infections, bone and joint infections. Pelvic inflammatory disease, endometritis, gonorrhea and other genital and tract infections. Prevention of infection: used to prevent infections caused by intra-abdominal, gynecological, cardiovascular and orthopedic surgeries.

Indication: This product is suitable for the treatment of the following infections caused by Staphylococcus aureus, Escherichia coli, Klebsiella pneumoniae, Proteus, Morganella morganii, Providencia, Peptostreptococcus, Bacteroides, Prevotella (except Prevotella biloba) that are sensitive to cefmetazole sodium: 1. Sepsis 2. Acute bronchitis, pneumonia, lung abscess, empyema, secondary infection of chronic respiratory diseases 3. Cystitis, pyelonephritis 4. Peritonitis 5. Cholecystitis, cholangitis 6. Bartholinitis, intrauterine infection, adnexitis, parametritis 7. Cellulitis around the jaws, jaw inflammation In the clinical studies (including double-blind trials) of 2,819 cases of intravenous injection, intravenous drip and intramuscular injection in 137 hospitals in Japan, the clinical results of 1,409 cases that can be judged as effective and belong to the approved indications of this product are as follows (for refractory or severe infections, the daily dose is increased to 4 grams (potency) for adults and 150 mg (potency) for children according to symptoms)/kg body weight): 1. Sepsis: The total effective rate for sepsis caused by Staphylococcus aureus, Escherichia coli and Klebsiella pneumoniae is 80.6% (25/31), and the dosage is 2-4g per day for adults and 50-150mg/kg for children. 2. Respiratory system infection: The total effective rate for respiratory tract infection caused by Staphylococcus aureus, Escherichia coli, Klebsiella pneumoniae, Proteus, Morganella morganii, Providencia, etc. is 79.7% (267/335). The dosage for drip or intravenous injection is 2-4g per day. In the double-blind trial, the efficacy of this product has been verified. 3. Biliary tract infection: This product is well excreted into bile and can reach a high concentration in bile. The total effective rate for cholecystitis and cholangitis caused by Escherichia coli and Klebsiella pneumoniae is 83.1% (49/59). The dosage is 2~4g per day. 4. Peritonitis: The total effective rate for peritonitis caused by Escherichia coli, Klebsiella pneumoniae, Bacteroides, Prevotella (except Prevotella biloba), etc. is 87.596 (161/184). Most of them are intravenous drips, and the dosage is 2~4g per day. 5. Urinary tract infection: The total effective rate for cystitis and pyelonephritis caused by Escherichia coli, Klebsiella pneumoniae, Proteus, Morganella kurschniki, Providencia, etc. is 73.1% (302/413). The dosage is mostly 1~2g per day. The results of a double-blind controlled trial on chronic complicated urinary tract infections have proved the efficacy of this product. 6. Gynecology and Obstetrics: The total effective rate for vestibular glanditis, intrauterine infection, adnexitis, and parametrial tissue inflammation caused by Escherichia coli, Klebsiella pneumoniae, Proteus mirabilis, Peptostreptococcus, Bacteroides, and Prevotella (except Prevotella biloba) is 94.796 (232/245). The dosage is usually 2-4g per day. 7. Oral Surgery: The total effective rate for perimandibular cellulitis and jaw inflammation caused by Peptostreptococcus is 83.896 (119/142). The dosage is usually 2-4g per day.

Indication: It is effective for the following infections caused by cefixime-infected bacteria from Streptococcus (except enterococci), Pneumococcus, Neisseria gonorrhoeae, Branhamella catarrhalis, Escherichia coli, Klebsiella, Serratia, Proteus, and Haemophilus influenzae. Acute exacerbation of chronic bronchitis, acute bronchitis with bacterial infection, bronchiectasis with infection, pneumonia; pyelonephritis, cystitis, gonococcal urethritis; acute bacterial infection of the biliary system (cholecystitis, cholangitis), scarlet fever; otitis media, sinusitis.

Indication: Suitable for cholecystitis and cholangitis.

Indication: Suitable for cholecystitis and cholangitis.